February 28, 2015 10:42 PM ET


Company Overview of Inviragen, Inc.

Company Overview

Inviragen, Inc. develops life-saving vaccines to protect against various infectious diseases in North America and internationally. It offers its products to protect against dengue viruses, as well as West Nile, swine-origin, chikungunya, plague/smallpox, and avian influenza diseases. The company's products also include INV21, a purified virus particle vaccine against hand, foot, and mouth disease. Inviragen, Inc. was founded in 2003 and is based in Fort Collins, Colorado. It has an additional office in Madison, Wisconsin. As of May 31, 2013, Inviragen, Inc. operates as a subsidiary of Takeda America Holdings, Inc.

2619 Midpoint Drive

Suite A

Fort Collins, CO 80525

United States

Founded in 2003





Key Executives for Inviragen, Inc.

Co-founder and Chief Executive Officer
Age: 60
Co-founder and Chief Scientific Officer
Chief Operating Officer
Chief Medical Officer
Regulatory Advisor
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
QPS Holdings, LLC United States
Advion Bioanalytical Labs, Inc. United States
Ferring Pharmaceuticals Inc. United States
Device Partners International, LLC United States
Kantata Pharmaceuticals United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Inviragen, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.